Cargando…
Integrated Metabolomics and Network Pharmacology to Establish the Action Mechanism of Qingrekasen Granule for Treating Nephrotic Syndrome
Nephrotic syndrome (NS) is a clinical syndrome resulting from abnormal glomerular permeability, mainly manifesting as edema and proteinuria. Qingrekasen granule (QRKSG), a Chinese Uyghur folk medicine, is a single-flavor preparation made from chicory (Cichorium intybus L.), widely used in treating d...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685401/ https://www.ncbi.nlm.nih.gov/pubmed/34938183 http://dx.doi.org/10.3389/fphar.2021.765563 |
_version_ | 1784617827478536192 |
---|---|
author | Duan, Yanfen Zhang, Dongning Ye, Yan Zheng, Sili Huang, Ping Zhang, Fengyun Mo, Guoyan Huang, Fang Yin, Qiang Li, Jingjing Han, Lintao |
author_facet | Duan, Yanfen Zhang, Dongning Ye, Yan Zheng, Sili Huang, Ping Zhang, Fengyun Mo, Guoyan Huang, Fang Yin, Qiang Li, Jingjing Han, Lintao |
author_sort | Duan, Yanfen |
collection | PubMed |
description | Nephrotic syndrome (NS) is a clinical syndrome resulting from abnormal glomerular permeability, mainly manifesting as edema and proteinuria. Qingrekasen granule (QRKSG), a Chinese Uyghur folk medicine, is a single-flavor preparation made from chicory (Cichorium intybus L.), widely used in treating dysuria and edema. Chicory, the main component in QRKSG, effectively treats edema and protects kidneys. However, the active components in QRKSG and its underlying mechanism for treating NS remain unclear. This study explored the specific mechanism and composition of QRKSG on an NS rat model using integrated metabolomics and network pharmacology. First, metabolomics explored the relevant metabolic pathways impacted by QRKSG in the treatment of NS. Secondly, network pharmacology further explored the possible metabolite targets. Afterward, a comprehensive network was constructed using the results from the network pharmacology and metabolomics analysis. Finally, the interactions between the active components and targets were predicted by molecular docking, and the differential expression levels of the target protein were verified by Western blotting. The metabolomics results showed “D-Glutamine and D-glutamate metabolism” and “Alanine, aspartate, and glutamate metabolism” as the main targeted metabolic pathways for treating NS in rats. AKT1, BCL2L1, CASP3, and MTOR were the core QRKSG targets in the treatment of NS. Molecular docking revealed that these core targets have a strong affinity for flavonoids, terpenoids, and phenolic acids. Moreover, the expression levels of p-PI3K, p-AKT1, p-mTOR, and CASP3 in the QRKSG group significantly decreased, while BCL2L1 increased compared to the model group. These findings established the underlying mechanism of QRKSG, such as promoting autophagy and anti-apoptosis through the expression of AKT1, CASP3, BCL2L1, and mTOR to protect podocytes and maintain renal tubular function. |
format | Online Article Text |
id | pubmed-8685401 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86854012021-12-21 Integrated Metabolomics and Network Pharmacology to Establish the Action Mechanism of Qingrekasen Granule for Treating Nephrotic Syndrome Duan, Yanfen Zhang, Dongning Ye, Yan Zheng, Sili Huang, Ping Zhang, Fengyun Mo, Guoyan Huang, Fang Yin, Qiang Li, Jingjing Han, Lintao Front Pharmacol Pharmacology Nephrotic syndrome (NS) is a clinical syndrome resulting from abnormal glomerular permeability, mainly manifesting as edema and proteinuria. Qingrekasen granule (QRKSG), a Chinese Uyghur folk medicine, is a single-flavor preparation made from chicory (Cichorium intybus L.), widely used in treating dysuria and edema. Chicory, the main component in QRKSG, effectively treats edema and protects kidneys. However, the active components in QRKSG and its underlying mechanism for treating NS remain unclear. This study explored the specific mechanism and composition of QRKSG on an NS rat model using integrated metabolomics and network pharmacology. First, metabolomics explored the relevant metabolic pathways impacted by QRKSG in the treatment of NS. Secondly, network pharmacology further explored the possible metabolite targets. Afterward, a comprehensive network was constructed using the results from the network pharmacology and metabolomics analysis. Finally, the interactions between the active components and targets were predicted by molecular docking, and the differential expression levels of the target protein were verified by Western blotting. The metabolomics results showed “D-Glutamine and D-glutamate metabolism” and “Alanine, aspartate, and glutamate metabolism” as the main targeted metabolic pathways for treating NS in rats. AKT1, BCL2L1, CASP3, and MTOR were the core QRKSG targets in the treatment of NS. Molecular docking revealed that these core targets have a strong affinity for flavonoids, terpenoids, and phenolic acids. Moreover, the expression levels of p-PI3K, p-AKT1, p-mTOR, and CASP3 in the QRKSG group significantly decreased, while BCL2L1 increased compared to the model group. These findings established the underlying mechanism of QRKSG, such as promoting autophagy and anti-apoptosis through the expression of AKT1, CASP3, BCL2L1, and mTOR to protect podocytes and maintain renal tubular function. Frontiers Media S.A. 2021-12-06 /pmc/articles/PMC8685401/ /pubmed/34938183 http://dx.doi.org/10.3389/fphar.2021.765563 Text en Copyright © 2021 Duan, Zhang, Ye, Zheng, Huang, Zhang, Mo, Huang, Yin, Li and Han. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Duan, Yanfen Zhang, Dongning Ye, Yan Zheng, Sili Huang, Ping Zhang, Fengyun Mo, Guoyan Huang, Fang Yin, Qiang Li, Jingjing Han, Lintao Integrated Metabolomics and Network Pharmacology to Establish the Action Mechanism of Qingrekasen Granule for Treating Nephrotic Syndrome |
title | Integrated Metabolomics and Network Pharmacology to Establish the Action Mechanism of Qingrekasen Granule for Treating Nephrotic Syndrome |
title_full | Integrated Metabolomics and Network Pharmacology to Establish the Action Mechanism of Qingrekasen Granule for Treating Nephrotic Syndrome |
title_fullStr | Integrated Metabolomics and Network Pharmacology to Establish the Action Mechanism of Qingrekasen Granule for Treating Nephrotic Syndrome |
title_full_unstemmed | Integrated Metabolomics and Network Pharmacology to Establish the Action Mechanism of Qingrekasen Granule for Treating Nephrotic Syndrome |
title_short | Integrated Metabolomics and Network Pharmacology to Establish the Action Mechanism of Qingrekasen Granule for Treating Nephrotic Syndrome |
title_sort | integrated metabolomics and network pharmacology to establish the action mechanism of qingrekasen granule for treating nephrotic syndrome |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685401/ https://www.ncbi.nlm.nih.gov/pubmed/34938183 http://dx.doi.org/10.3389/fphar.2021.765563 |
work_keys_str_mv | AT duanyanfen integratedmetabolomicsandnetworkpharmacologytoestablishtheactionmechanismofqingrekasengranulefortreatingnephroticsyndrome AT zhangdongning integratedmetabolomicsandnetworkpharmacologytoestablishtheactionmechanismofqingrekasengranulefortreatingnephroticsyndrome AT yeyan integratedmetabolomicsandnetworkpharmacologytoestablishtheactionmechanismofqingrekasengranulefortreatingnephroticsyndrome AT zhengsili integratedmetabolomicsandnetworkpharmacologytoestablishtheactionmechanismofqingrekasengranulefortreatingnephroticsyndrome AT huangping integratedmetabolomicsandnetworkpharmacologytoestablishtheactionmechanismofqingrekasengranulefortreatingnephroticsyndrome AT zhangfengyun integratedmetabolomicsandnetworkpharmacologytoestablishtheactionmechanismofqingrekasengranulefortreatingnephroticsyndrome AT moguoyan integratedmetabolomicsandnetworkpharmacologytoestablishtheactionmechanismofqingrekasengranulefortreatingnephroticsyndrome AT huangfang integratedmetabolomicsandnetworkpharmacologytoestablishtheactionmechanismofqingrekasengranulefortreatingnephroticsyndrome AT yinqiang integratedmetabolomicsandnetworkpharmacologytoestablishtheactionmechanismofqingrekasengranulefortreatingnephroticsyndrome AT lijingjing integratedmetabolomicsandnetworkpharmacologytoestablishtheactionmechanismofqingrekasengranulefortreatingnephroticsyndrome AT hanlintao integratedmetabolomicsandnetworkpharmacologytoestablishtheactionmechanismofqingrekasengranulefortreatingnephroticsyndrome |